Tempest Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
985
across all filing types
Latest filing
2026-06-01
Regulatory Filings
Country
US
United States of America
Listing
US
TPST
Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates and cell therapies. The company develops first-in-class therapeutics that combine tumor-targeted and immune-mediated mechanisms to treat cancer. Its lead product candidate is amezalpat (TPST-1120), an oral, selective PPARα antagonist being evaluated in a global, randomized combination study for hepatocellular carcinoma. In addition to its small molecule platform, the company is also developing dual-chimeric antigen receptor (CAR) T-cell programs.
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47932149 | 8-K | 2026-06-01 | English | ||
| 47894406 | 8-K | 2026-05-29 | English | ||
| 46862577 | 8-K | 2026-05-22 | English | ||
| 46861258 | 8-K | 2026-05-22 | English | ||
| 46273317 | 10-Q | 2026-05-14 | English | ||
| 46272554 | 8-K | 2026-05-14 | English | ||
| 41819645 | 8-K - Tempest Therapeutics, Inc. (0001544227) (Filer) | 2026-05-06 | English | ||
| 33995585 | 424B3 - Tempest Therapeutics, Inc. (0001544227) (Filer) | 2026-04-10 | English | ||
| 33995582 | 424B3 - Tempest Therapeutics, Inc. (0001544227) (Filer) | 2026-04-10 | English | ||
| 33111031 | S-8 POS - Tempest Therapeutics, Inc. (0001544227) (Filer) | 2026-03-31 | English | ||
| 33088252 | 10-K - Tempest Therapeutics, Inc. (0001544227) (Filer) | 2026-03-30 | English | ||
| 33088089 | 8-K - Tempest Therapeutics, Inc. (0001544227) (Filer) | 2026-03-30 | English | ||
| 33043165 | SCHEDULE 13D/A - Tempest Therapeutics, Inc. (0001544227) (Subject) | 2026-03-25 | English | ||
| 33043162 | 4 - Tempest Therapeutics, Inc. (0001544227) (Issuer) | 2026-03-25 | English | ||
| 33013170 | 8-K - Tempest Therapeutics, Inc. (0001544227) (Filer) | 2026-03-23 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
EXICURE, INC.
Early-stage biotech developing nucleic acid therapies based…
|
XCUR | US | Professional, scientific and te… |
|
EyeGene,Inc
Develops gene/cell therapies for age-related diseases and p…
|
185490 | KR | Professional, scientific and te… |
|
Femtobiomed Inc.
Develops a non-viral intracellular delivery platform for ce…
|
327610 | KR | Professional, scientific and te… |
|
Fermi Inc.
Develops AI data center campuses with co-located hybrid pow…
|
FRMI | US | Professional, scientific and te… |
|
Fluicell AB
A biotech firm creating engineered tissues for regenerative…
|
FLUI | SE | Professional, scientific and te… |
|
Flydoo Technology Holding Limited
Provides comprehensive travel services, package tours, and …
|
8069 | HK | Professional, scientific and te… |
|
Foghorn Therapeutics Inc.
Develops medicines targeting the chromatin regulatory syste…
|
FHTX | US | Professional, scientific and te… |
|
Fortrea Holdings Inc.
A global CRO providing clinical development and patient acc…
|
FTRE | US | Professional, scientific and te… |
|
Foxtron
Specializes in electric vehicle design, open platforms, and…
|
2258 | TW | Professional, scientific and te… |
|
FRMSP
Develops ophthalmology and oncology therapies using proprie…
|
6838 | TW | Professional, scientific and te… |
Tempest Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34632/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34632 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34632 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34632 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34632}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Tempest Therapeutics, Inc. (id: 34632)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.